SCHEMBL18646647

SCHEMBL18646647

C#CCCC[C@H](NC)C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.39
CYP1A2 P05177 2/20 0.39
CYP2D6 P10635 2/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
HSD17B10 Q99714 1/20 0.39
ALDH1A1 P00352 2/20 0.35
KDM4E B2RXH2 2/20 0.35
HPGD P15428 1/20 0.35
CYP3A4 P08684 3/20 0.34
USP2 O75604 2/20 0.34
MEN1 O00255 1/20 0.34
TP53 P04637 1/20 0.34
MAPK1 P28482 1/20 0.34
KMT2A Q03164 1/20 0.34
NOD1 Q9Y239 1/20 0.33
FOLH1 Q04609 5/20 0.32
GNPAT O15228 1/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
RIMKLA Q8IXN7 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13881436 0.88 MAPT (0.33) MAPTCYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL13034838 0.83 CYP1A2 (0.34) MAPTCYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL13745511 0.81 SMN1; SMN2 (0.48) MAPTCYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL1082586 0.79 NOD1 (0.43) MAPTALDH1A1KDM4ENOD1FOLH1
SCHEMBL13267743 0.77 USP2 (0.44) MAPTCYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL13130795 0.76 FOLH1 (0.41) MEN1KMT2ANOD1FOLH1SMN1; SMN2
SCHEMBL8767803 0.75 NOD1 (0.37) MAPTALDH1A1KDM4ENOD1FOLH1
SCHEMBL288045 0.75 CA2 (0.50) MAPTMAPK1NOD1
SCHEMBL201058 0.75 CA2 (0.50) MAPTMAPK1NOD1
SCHEMBL429475 0.75 CA2 (0.50) MAPTMAPK1NOD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017044633-A1 PEPTIDOMIMETIC MACROCYCLES AS MODULATORS OF MCL-1 AILERON THERAPEUTICS, INC. (US) 2017-03-16 WO disclosed